Exclusive Sage, senior living operating system, raises 35 million Series B led by IVP

SAGE Stock  USD 5.54  0.19  3.32%   
About 55% of Sage Therapeutic's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Sage Therapeutic suggests that some traders are interested. The current market sentiment, together with Sage Therapeutic's historical and current headlines, can help investors time the market. In addition, many technical investors use Sage Therapeutic stock news signals to limit their universe of possible portfolio assets.
  
Sage has raised a 35 million Series B, led by IVP, Fortune can exclusively report.

Read at finance.yahoo.com
Yahoo News
  

Sage Therapeutic Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Sage Therapeutic can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sage Therapeutic Fundamental Analysis

We analyze Sage Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sage Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sage Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Sage Therapeutic is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Sage Therapeutic Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sage Therapeutic stock to make a market-neutral strategy. Peer analysis of Sage Therapeutic could also be used in its relative valuation, which is a method of valuing Sage Therapeutic by comparing valuation metrics with similar companies.

Peers

Sage Therapeutic Related Equities

VTYXVentyx Biosciences   2.15   
0%
43.0%
DMACDiaMedica Therapeutics   1.31   
0%
26.0%
DAWNDay One   0.23   
4.0%
0%
MDGLMadrigal Pharmaceuticals   0.30   
6.0%
0%
ARVNArvinas   0.42   
8.0%
0%
INCYIncyte   0.47   
9.0%
0%
KRYSKrystal Biotech   0.75   
15.0%
0%
APLSApellis Pharmaceuticals   0.85   
17.0%
0%
STOKStoke Therapeutics   1.60   
32.0%
0%
TERNTerns Pharmaceuticals   1.87   
38.0%
0%
ALNYAlnylam Pharmaceuticals   1.87   
38.0%
0%
RLAYRelay Therapeutics   2.02   
41.0%
0%
NUVLNuvalent   2.14   
43.0%
0%
AKROAkero Therapeutics   2.22   
45.0%
0%
BPMCBlueprint Medicines   2.42   
49.0%
0%
PLRXPliant Therapeutics   3.35   
68.0%
0%
IMCRImmunocore Holdings   3.44   
70.0%
0%
BDTXBlack Diamond   4.78   
97.0%
0%
AMLXAmylyx Pharmaceuticals   4.91   
100.0%
0%

Complementary Tools for Sage Stock analysis

When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stocks Directory
Find actively traded stocks across global markets